Exponential View
Exponential View by Azeem Azhar
🔮 Lifespan, AI in healthcare, GLP-1 drugs, and mRNA with Dr Eric Topol
Preview
0:00
-21:09

🔮 Lifespan, AI in healthcare, GLP-1 drugs, and mRNA with Dr Eric Topol

Can AI restore care in healthcare?

Four years ago — some of you may remember — I spoke with the renowned cardiologist and researcher

. On that occasion, he shared that “AI could restore the care in healthcare”. Fast forward to 2024, Eric and I come together to compare our notes — on the pandemic, the AI wave, and the major technological developments shaping healthcare and medical science today. Eric’s newsletter Ground Truths is the place to go for the latest updates on the scientific and technological developments in medicine.

In this conversation, Eric and I cover…

  • How to approach healthy aging, healthspan and lifespan,

  • Personalised medicine and the uptick in scanning — balancing between evidence and affluenza,

  • How generative AI and LLMs can be major accelerants in healthcare,

  • The power of temperance drugs — reviewing the impact of GLP-1 agonists (like Ozempic),

  • Gene editing and mRNA as the biggest breakthroughs in life sciences of our generation,

  • Funding models and policy infrastructure needed to support future breakthroughs,

  • …and what is on our (medical) New Year’s wishlist.

We recorded for over 1 hour — and the full length of our discussion is available to paying members of Exponential View, who also have access to all of my previous discussions:

✨ If I had to pick one AI tool... this would be it.

·
November 17, 2023
✨ If I had to pick one AI tool... this would be it.

There are so many new artificial intelligence products out there. Which ones are really worth your time? If I had to pick one, it wouldn’t be ChatGPT or Claude. It would be Perplexity.ai. Since 1 October I’ve logged more than 268 queries on Perplexity from my laptop alone (I use it on my phone, too). It’s displacing a large number of my Google searches.

🐙 AI is in business — I caught up with Andrew Ng

·
December 1, 2023
🐙 AI is in business — I caught up with Andrew Ng

Since ChatGPT was released a year ago, organisations across the world have been grappling with the rise of generative AI. What have they learnt, and what are their most common mistakes? Are we at an inflection point in the AI revolution, and how can regulation support its development?

This post is for paid subscribers